[Thermal injuries of the hand by treatment with dextranomer (Debrisorb)].
On the basis of our clinical observation we see the main mode of operation of DEBRISORB is due to the distinctly hydrophilic action of the substance, thereby reducing oedema, improving the microcirculation and limiting cell necrosis. It also acts by absorbing the toxic secretions of injuries which stimulate inflammation. Another great advantage is the increased possibility of early physiotherapy by which the risk of a residual joint contracture is reduced.
D000328:Adult; D002056:Burns / Q000628:therapy*; D003911:Dextrans / Q000627:therapeutic use*; D006230:Hand Injuries / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014945:Wound Healing / Q000187:drug effects
D003911:Dextrans; C013471:dextranomer
Thermische Verletzungen der Hand bei Behandlung mit Dextranomer (Debrisorb).